针对局部晚期直肠癌的全新辅助疗法:如何选择最合适的?
1Division of Medical Oncology, Department of Internal Medicine, Faculty of Medicine, Navamindradhiraj University, Bangkok 10300, Thailand.
Journal of clinical medicine
|September 14, 2024
概括
全新辅助疗法 (TNT) 是对高风险直肠癌的新方法,有可能改善无病生存率. 本综述检查了新辅助疗法,以个性化治疗局部晚期直肠癌 (LARC).
科学领域:
- 在瘤学瘤学.
- 胃肠道手术 胃肠道手术
- 辐射瘤学 辐射瘤学
背景情况:
- 局部晚期直肠癌 (LARC) 的复发率很高,需要有效的治疗策略.
- 标准的新辅助化学辐射疗法改善了局部控制,但对高风险和低风险病变有局限性.
- 在LARC中,新辅助疗法的整体生存益处仍在调查中.
研究的目的:
- 审查关于直肠癌新辅助疗法的现有证据.
- 探索全新辅助疗法 (TNT) 在高风险直肠癌管理中的作用.
- 为LARC提出基于风险分层的个性化管理模式.
主要方法:
- 对LARC的新辅助疗法现有文献的审查.
- 分析与标准的新辅助化学放射治疗相关的结果.
- 对新兴的全新辅助疗法 (TNT) 方法的评估.
主要成果:
- 标准的新辅助化学辐射疗法将局部复发率降低到6-7%,但在一些患者中会导致长期的疾病.
- 在高风险的直肠癌中,TNT显示出改善无疾病生存率的潜力.
- 单独使用新辅助化学疗法对低风险直肠癌的化学放射疗法没有劣势.
结论:
- 对于LARC,需要针对新辅助疗法的量身定制方法,考虑个体风险因素.
- 在高风险的直肠癌中,TNT代表了优化治疗结果的有希望的策略.
- 需要进一步的研究来确定TNT的生存益处和最佳测序.
更多相关视频
相关概念视频
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Tumor Immunotherapy
2.5K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K


